WN
AVNS

Williams & Novak’s Avanos Medical AVNS Stock Holding History

Williams & Novak’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,348
Closed -$371K – 149
2026
Q1 		$371K Sell
26,348
-7,964
-23% -$107K 0.28% 76
2025
Q4 		$385K Buy
34,312
+627
+2% +$7.17K 0.29% 78
2025
Q3 		$389K Buy
33,685
+11,466
+52% +$134K 0.3% 74
2025
Q2 		$272K Buy
22,219
+9,250
+71% +$116K 0.23% 87
2025
Q1 		$186K Buy
+12,969
New +$202K 0.18% 95

Other funds holding AVNS

SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Williams & Novak's AVNS Position: Q2 2026 in Review

Williams & Novak sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 26,348 shares — an estimated $371K sold.

Williams & Novak first reported a position in AVNS in Q1 2025 and held it in 5 quarters. The position peaked at $389K in Q3 2025. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Williams & Novak reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Williams & Novak sold 26,348 Avanos Medical shares in Q2 2026, an estimated $371K.
  • Williams & Novak first reported a position in Avanos Medical in Q1 2025 and held it in 5 quarters.
  • Williams & Novak's Avanos Medical position peaked at $389K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Williams & Novak's 13F filing for Q2 2026, filed 8 Jul 2026.